Concepedia

Chlamydia trachomatis and Anti-MUC1 Serology and Subsequent Risk of High-Grade Serous Ovarian Cancer: A Population-Based Case–Control Study in Northern Sweden

Sarah Jonsson, Eva Lundin, Fredrik Elgh, Ulrika Ottander, Annika Idahl

Translational Oncology · 2019 · 11 citations · 26 references

DOIFull text

Open access

Abstract

The findings of this prospective nested case-control study did not support an association between C. trachomatis infection, as measured by chlamydial serology, or anti-MUC1 IgG antibodies, and subsequent risk of HGSC.

References

26

Inhibition of Apoptosis in Chlamydia-infected Cells: Blockade of Mitochondrial Cytochrome c Release and Caspase Activation

Tao Fan, Hang Lu, He Hu et al. · The Journal of Experimental Medicine · 1998 · 586 citations · Full text

Ovarian Cancer Risk Factors by Histologic Subtype: An Analysis From the Ovarian Cancer Cohort Consortium

Nicolas Wentzensen, Elizabeth M. Poole, Britton Trabert et al. · Journal of Clinical Oncology · 2016 · 499 citations · Full text

Morphologic and antigenic characterization of interferon gamma-mediated persistent Chlamydia trachomatis infection in vitro.

Wandy L. Beatty, G I Byrne, Richard P. Morrison · Proceedings of the National Academy of Sciences · 1993 · 476 citations · Full text

, , +8

The Västerbotten Intervention Programme: background, design and implications

Margareta Norberg, Stig Wall, Kurt Boman et al. · Global Health Action · 2010 · 357 citations · Full text

Tryptophan depletion as a mechanism of gamma interferon-mediated chlamydial persistence

Wandy L. Beatty, Theodore A. Belanger, A. A. DESAI et al. · Infection and Immunity · 1994 · 343 citations · Full text

, , +12